Orchid Pharma rose 1.78% to Rs 37.20 at 14:21 IST on BSE, with the stock extending yesterday's rally after receiving the Establishment Inspection Report from the United States Food and Drug Administration. Business Standard, 1 week ago
Orchid Pharma spurts after securing EIR for unit - Business Standard, 1 week ago
Orchid Pharma soars 14% on establishment inspection report for Tamil Nadu unit - Money Control, 1 week ago
Drug firm Orchid Pharma today said the US health regulator has issued establishment inspection report (EIR) for its manufacturing facility in Tamil Nadu.DNA, 1 week ago
According to Prakash Gaba of prakashgaba.com, one may exit Orchid Pharma.Money Control, 3 weeks ago Sell Orchid Pharma on rally, says Vijay Chopra Money Control, 3 weeks ago Exit Orchid Pharma closer to Rs 36: Prakash Gaba Money Control, 2 months ago Exit Orchid Pharma; pick Lupin, Sun Pharma: Avinash Gorakshakar Money Control, 2 months ago
Drug firm Orchid Pharma's standalone net loss narrowed to Rs 60.97 crore during the quarter ended December 31, 2016. The company had posted a net loss of Rs 94.02 crore in the year-ago period, Orchid Pharma said in a BSE filing. Its standalone total income ...Business Standard, 2 months ago
Posted by Equitymaster Asian equity markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.34%, while the Hang Seng is down 0.78%. The Nikkei 225 is trading lower by 0.48%. The US equities closed slightly higher amid ...Equitymaster.com, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!